Ten-minute tests get €2m investment
- Company:Hibergene Diagnostics
- Done deal:€2 million
- The clincher:“There is a significant market need for accurate, rapid, cost-effective and simple to use near-patient clinical testing for critical care infectious diseases.” – Orla Rimmington, partner, Kernel Capital
Dublin med-tech firm HiberGene Diagnostics has closed a €2 million funding round to bring to market its first two products.
A ...